Kinji Itoh

497 total citations
9 papers, 415 citations indexed

About

Kinji Itoh is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Cancer Research. According to data from OpenAlex, Kinji Itoh has authored 9 papers receiving a total of 415 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Pathology and Forensic Medicine and 4 papers in Cancer Research. Recurrent topics in Kinji Itoh's work include Lymphoma Diagnosis and Treatment (4 papers), NF-κB Signaling Pathways (4 papers) and T-cell and Retrovirus Studies (2 papers). Kinji Itoh is often cited by papers focused on Lymphoma Diagnosis and Treatment (4 papers), NF-κB Signaling Pathways (4 papers) and T-cell and Retrovirus Studies (2 papers). Kinji Itoh collaborates with scholars based in Japan, United States and Australia. Kinji Itoh's co-authors include Ryouichi Horie, Toshiki Watanabe, Masaaki Higashihara, Mariko Watanabe, Marshall E. Kadin, Masataka Sasaki, Yukio Ishikawa, Kazuo Umezawa, Takao MASUDA and Hideko Kiguchi and has published in prestigious journals such as Cancer Cell, Cancer Research and Oncogene.

In The Last Decade

Kinji Itoh

9 papers receiving 407 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kinji Itoh Japan	8	149	143	119	115	97	9	415
Stephen Brady United States	7	69 0.5×	122 0.9×	32 0.3×	74 0.6×	57 0.6×	7	397
Luk Cox Belgium	9	86 0.6×	195 1.4×	59 0.5×	34 0.3×	22 0.2×	12	432
Renate E. Gay United States	7	71 0.5×	165 1.2×	118 1.0×	17 0.1×	86 0.9×	7	497
Ulf M�ller-Ladner Germany	6	119 0.8×	77 0.5×	116 1.0×	39 0.3×	15 0.2×	8	322
MQ Du United Kingdom	6	178 1.2×	95 0.7×	91 0.8×	29 0.3×	74 0.8×	7	327
Geetha Menezes United States	8	132 0.9×	117 0.8×	30 0.3×	50 0.4×	66 0.7×	12	385
Ambra V. Gualeni Italy	12	85 0.6×	219 1.5×	64 0.5×	78 0.7×	159 1.6×	19	470
Maria Antonella Laginestra Italy	12	151 1.0×	147 1.0×	82 0.7×	38 0.3×	104 1.1×	25	382
Caterina Matteucci Italy	15	114 0.8×	219 1.5×	89 0.7×	30 0.3×	40 0.4×	49	604
Jennifer Anderton United Kingdom	8	60 0.4×	273 1.9×	57 0.5×	97 0.8×	64 0.7×	9	440

Countries citing papers authored by Kinji Itoh

Since Specialization

Citations

This map shows the geographic impact of Kinji Itoh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kinji Itoh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kinji Itoh more than expected).

Fields of papers citing papers by Kinji Itoh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kinji Itoh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kinji Itoh. The network helps show where Kinji Itoh may publish in the future.

Co-authorship network of co-authors of Kinji Itoh

This figure shows the co-authorship network connecting the top 25 collaborators of Kinji Itoh. A scholar is included among the top collaborators of Kinji Itoh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kinji Itoh. Kinji Itoh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Togano, Tomiteru, Mariko Watanabe, Kinji Itoh, et al.. (2013). Activation of Akt involves resistance to NF-κB inhibition and abrogation of both triggers synergistic apoptosis in lung adenocarcinoma cells. Lung Cancer. 83(2). 139–145. 2 indexed citations

2.

Watanabe, Mariko, Kinji Itoh, Tomiteru Togano, et al.. (2011). Ets-1 Activates Overexpression of JunB and CD30 in Hodgkin's Lymphoma and Anaplastic Large-Cell Lymphoma. American Journal Of Pathology. 180(2). 831–838. 24 indexed citations

3.

Watanabe, Mariko, Yuji Ogawa, Kinji Itoh, et al.. (2007). Hypomethylation of CD30 CpG islands with aberrant JunB expression drives CD30 induction in Hodgkin lymphoma and anaplastic large cell lymphoma. Laboratory Investigation. 88(1). 48–57. 34 indexed citations

4.

Horie, Ryouichi, et al.. (2005). Aberrant NF-κB2/p52 expression in Hodgkin/Reed–Sternberg cells and CD30-transformed rat fibroblasts. Oncogene. 24(24). 3976–3986. 33 indexed citations

5.

Watanabe, Mariko, Masataka Sasaki, Kinji Itoh, et al.. (2005). JunB Induced by Constitutive CD30–Extracellular Signal-Regulated Kinase 1/2 Mitogen-Activated Protein Kinase Signaling Activates the CD30 Promoter in Anaplastic Large Cell Lymphoma and Reed-Sternberg Cells of Hodgkin Lymphoma. Cancer Research. 65(17). 7628–7634. 103 indexed citations

6.

Horie, Ryouichi, Mariko Watanabe, Takaomi Ishida, et al.. (2004). The NPM-ALK oncoprotein abrogates CD30 signaling and constitutive NF-κB activation in anaplastic large cell lymphoma. Cancer Cell. 5(4). 353–364. 63 indexed citations

7.

Watanabe, Mariko, Md. Zahidunnabi Dewan, Masataka Sasaki, et al.. (2004). A novel NF-?B inhibitor DHMEQ selectively targets constitutive NF-?B activity and induces apoptosis of multiple myeloma cellsin vitro andin vivo. International Journal of Cancer. 114(1). 32–38. 62 indexed citations

8.

MASUDA, Takao, Yukio Ishikawa, Yoshikiyo Akasaka, et al.. (2001). The effect of myocardial bridging of the coronary artery on vasoactive agents and atherosclerosis localization. The Journal of Pathology. 193(3). 408–414. 83 indexed citations

9.

MASUDA, Takao, Yukio Ishikawa, Yoshikiyo Akasaka, et al.. (2001). The effect of myocardial bridging of the coronary artery on vasoactive agents and atherosclerosis localization. The Journal of Pathology. 193(3). 408–414. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact